ArticleCancer research and treatment2025

The Histone Deacetylase Inhibitor Entinostat Mediates HER2 Downregulation in Gastric Cancer, Providing the Basis for Its Particular Efficacy in HER2-Amplified Tumors and in Combination Therapies.

Tamara Zenz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.